Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0677 in Hip Fracture Recovery
NCT00128115Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Sep 2005
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ibutamoren in hip fracture, Sarcopenia, sponsored by Merck & Co.. Started Sep 2005; status: terminated.
02
Drugs
ibutamoren
03
Conditions
hip fractureSarcopenia
Beyond the preview
Go deeper on NCT00128115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128115.